Kai Lopau

1.6k total citations
39 papers, 920 citations indexed

About

Kai Lopau is a scholar working on Nephrology, Transplantation and Surgery. According to data from OpenAlex, Kai Lopau has authored 39 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 14 papers in Transplantation and 11 papers in Surgery. Recurrent topics in Kai Lopau's work include Renal Transplantation Outcomes and Treatments (14 papers), Organ Donation and Transplantation (9 papers) and Organ Transplantation Techniques and Outcomes (7 papers). Kai Lopau is often cited by papers focused on Renal Transplantation Outcomes and Treatments (14 papers), Organ Donation and Transplantation (9 papers) and Organ Transplantation Techniques and Outcomes (7 papers). Kai Lopau collaborates with scholars based in Germany, Switzerland and United States. Kai Lopau's co-authors include Christoph Wanner, E. Heidbreder, Peter Schnuelle, Lawrence P. Schramm, H. Ebel, Helmut Arbogast, Jana Noeldeke, U.‐S. Albert, Guido G. Persijn and Corrado Bernasconi and has published in prestigious journals such as JAMA, Kidney International and The Journal of Urology.

In The Last Decade

Kai Lopau

37 papers receiving 900 citations

Peers

Countries citing papers authored by Kai Lopau

Since Specialization

Citations

This map shows the geographic impact of Kai Lopau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Lopau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Lopau more than expected).

Fields of papers citing papers by Kai Lopau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Lopau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Lopau. The network helps show where Kai Lopau may publish in the future.

Co-authorship network of co-authors of Kai Lopau

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Lopau. A scholar is included among the top collaborators of Kai Lopau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Lopau. Kai Lopau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human Leucocyte Antigen–Matching Can Improve Long Term Outcome of Renal Allografts from Donors Older Than 75 Years 2023 ·Transplantation Proceedings ·Martina Koch, Daniel Zecher, Kai Lopau, Julia Weinmann‐Menke, (unknown), Björn Nashan, Ulrich Wenzel, Bernhard Banas, Martin Zeier, Friedrich Thaiss, Claudia Sommerer	1
2	Fixed low dose versus concentration-controlled initial tacrolimus dosing with reduced target levels in the course after kidney transplantation: results from a prospective randomized controlled non-inferiority trial (Slow & Low study) 2023 ·EClinicalMedicine ·Julian Stumpf, Klemens Budde, Oliver Witzke, Claudia Sommerer, Thomas Vogel, Peter Schenker, Rainer P. Woitas, (unknown), Evelyn Trips, Eva Schrezenmeier, Christian Hugo, Matthias Girndt, Günter Wolf, Christine Kurschat, Kai Lopau, Jens Lutz	2
3	Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study) 2023 ·Nephrology Dialysis Transplantation ·Julian Stumpf, Oliver Thomusch, (unknown), Michael S. Wiesener, Andreas Pascher, Rainer P. Woitas, Barbara Suwelack, Markus Rentsch, Oliver Witzke, Timo Räth, Bernhard Banas, Urs Benck, Claudia Sommerer, Christine Kurschat, Kai Lopau, Julia Weinmann‐Menke, (unknown), Evelyn Trips, Christian Hugo	7
4	The safety and feasibility of incremental dialysis must be proven before its widespread use 2022 ·Kidney International ·Christoph Wanner, Kai Lopau, (unknown)	3
5	Color-coded summation images in the evaluation of renal artery stenosis before and after percutaneous transluminal angioplasty 2021 ·BMC Medical Imaging ·Anne Marie Augustin, Stefan Welsch, Thorsten Alexander Bley, Kai Lopau, Ralph Kickuth	3
6	Treatment rationale for coronary heart disease in advanced CKD 2021 ·Herz ·Kai Lopau, Christoph Wanner	1
7	The transition clinic in chronic kidney disease care 2020 ·Nephrology Dialysis Transplantation ·Marie Evans, Kai Lopau	22
8	First Treatment of Relapsing Rapidly Progressive IgA Nephropathy With Eculizumab After Living Kidney Donation: A Case Report 2017 ·Transplantation Proceedings ·(unknown), Christoph Wanner, Kerstin Amann, Kai Lopau	32
9	Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer 2014 ·World Journal of Urology ·Daniel Vergho, Maximilian Burger, (unknown), Sabine Brookman‐May, Michael Gierth, B. Hoschke, Kai Lopau, Christian Gilfrich, H. Riedmiller, Ingmar Wolff, Matthias May	7
10	Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients 2011 ·Kidney International ·Igor Tsaur, Martin Gasser, (unknown), Jens Lutz, (unknown), Martin Grimm, Volkmar Lange, Kai Lopau, Uwe Heemann, Christoph‐Thomas Germer, Anil Chandraker, Ana Maria Waaga-Gasser	18
11	Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients 2010 ·Nephrology Dialysis Transplantation ·Frank Eitner, I.A. Hauser, (unknown), Timo Räth, Kai Lopau, Rainer U. Pliquett, Roman Fiedler, Markus Guba, R.-D Hilgers, J. Floege, Michael Fischereder	57
12	99 RENAL TRANSPLANTATION INTO CONTINENT URINARY RESERVOIRS: LONG-TERM FOLLOW UP 2009 ·European Urology Supplements ·Arkadius Kocot, Martin Spahn, (unknown), Kai Lopau, H. Riedmiller	1
13	MRT bei Nierentransplantatdysfunktion: Gibt es typische Diagnosen im frühen und späten postoperativen Verlauf? 2008 ·Aktuelle Urologie ·Markus Weininger, (unknown), Kai Lopau, Thomas Pabst, W. Kenn, H. Riedmiller, D. Hahn, M Beissert	1
14	Antiphospholipidantikörpersyndrom: a priori eine Kontraindikation zur Nierentransplantation? 2007 ·Aktuelle Urologie ·Peter Rubenwolf, Kai Lopau, (unknown), (unknown), H. Riedmiller	2
15	Effects of Pravastatin Treatment on Blood Pressure Regulation after Renal Transplantation 2006 ·Kidney & Blood Pressure Research ·Kai Lopau, (unknown), Christoph Wanner	4
16	Efficacy and safety of preemptive anti‐CMV therapy with valganciclovir after kidney transplantation 2006 ·Clinical Transplantation ·Kai Lopau, (unknown), Christoph Wanner	15
17	Advanced renal insufficiency in a 34-year-old man with Lowe syndrome 2004 ·American Journal of Kidney Diseases ·Lothar Schramm, Andreas Gal, Josef Zimmermann, (unknown), E. Heidbreder, Kai Lopau, H.-J. Gröne, Christoph Wanner	12
18	L-Arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation 2002 ·Kidney International ·Lothar Schramm, Mylinh La, E. Heidbreder, Markus Hecker, (unknown), Kai Lopau, Josef Zimmermann, J. Rendl, Christoph Reiners, (unknown), Christoph Wanner, Harald Schmidt	68
19	Effects of Urodilatin and Diltiazem on Renal Function in Ischemic Acute Renal Failure in the Rat 1995 ·American Journal of Nephrology ·Lothar Schramm, E. Heidbreder, (unknown), (unknown), Josef Zimmermann, Kai Lopau, Hong Ling, A. Heidland	5
20	Toxic Acute Renal Failure in the Rat: Effects of Diltiazem and Urodilatin on Renal Function 1994 ·The Nephron journals/Nephron journals ·(unknown), E. Heidbreder, Johan Schaar, Kai Lopau, (unknown), (unknown), Hong Ling, A. Heidland	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact